[HTML][HTML] TNFR1 and TNFR2, which link NF-κB activation, drive lung cancer progression, cell dedifferentiation, and metastasis
G Shi, Y Hu - Cancers, 2023 - mdpi.com
Simple Summary This review discusses new findings for the roles of TNFR1 and TNFR2 in
the development of aggressive lung squamous cell carcinoma and lung adenocarcinoma by …
the development of aggressive lung squamous cell carcinoma and lung adenocarcinoma by …
[HTML][HTML] A TNFR1–UBCH10 axis drives lung squamous cell carcinoma dedifferentiation and metastasis through a cell-autonomous signaling loop
Tumor necrosis factor receptor 1 (TNFR1), encoded by TNFRSF1A, is a critical transducer of
inflammatory pathways, but its physiological role in human cancer is not completely …
inflammatory pathways, but its physiological role in human cancer is not completely …
Expression of tumor necrosis factor receptor 2 in human non‐small cell lung cancer and its role as a potential prognostic biomarker
YW Zhang, QQ Chen, J Cao, LQ Xu, X Tang… - Thoracic …, 2019 - Wiley Online Library
Background Tumor necrosis factor receptor 2 (TNFR2) promotes tumor cell proliferation,
activates immunosuppressive cells, and supports immune escape. However, its role in non …
activates immunosuppressive cells, and supports immune escape. However, its role in non …
TNFR2 pathways are fully active in cancer regulatory T cells
Y Okuzono, Y Muraki, S Sato - Bioscience, Biotechnology, and …, 2022 - academic.oup.com
Tumor necrosis factor receptor 2 (TNFR2), a membrane-bound tumor necrosis factor
receptor expressed by regulatory T cells (Tregs), participates in Treg proliferation. Although …
receptor expressed by regulatory T cells (Tregs), participates in Treg proliferation. Although …
[HTML][HTML] TNF receptor 2 makes tumor necrosis factor a friend of tumors
Y Sheng, F Li, Z Qin - Frontiers in immunology, 2018 - frontiersin.org
Tumor necrosis factor (TNF) is widely accepted as a tumor-suppressive cytokine via its
ubiquitous receptor TNF receptor 1 (TNFR1). The other receptor, TNFR2, is not only …
ubiquitous receptor TNF receptor 1 (TNFR1). The other receptor, TNFR2, is not only …
[HTML][HTML] MRTF-A-NF-κB/p65 axis-mediated PDL1 transcription and expression contributes to immune evasion of non-small-cell lung cancer via TGF-β
F Du, X Qi, A Zhang, F Sui, X Wang, CG Proud… - … & Molecular Medicine, 2021 - nature.com
PD-L1 is abnormally regulated in many cancers and is critical for immune escape. Fully
understanding the regulation of PD-L1 expression is vital for improving the clinical efficacy of …
understanding the regulation of PD-L1 expression is vital for improving the clinical efficacy of …
[HTML][HTML] Targeting TNFR2: A novel breakthrough in the treatment of cancer
M Li, X Zhang, X Bai, T Liang - Frontiers in Oncology, 2022 - frontiersin.org
Tumour necrosis factor (TNF) receptor type II (TNFR2) is expressed in various tumour cells
and some immune cells, such as regulatory T cells and myeloid-derived suppressing cells …
and some immune cells, such as regulatory T cells and myeloid-derived suppressing cells …
[HTML][HTML] The diverse roles of the TNF axis in cancer progression and metastasis
B Ham, MC Fernandez, Z D'costa… - Trends in cancer …, 2016 - ncbi.nlm.nih.gov
Metastasis is a multi-step process that ultimately depends on the ability of disseminating
cancer cells to establish favorable communications with their microenvironment. The tumor …
cancer cells to establish favorable communications with their microenvironment. The tumor …
[HTML][HTML] The roles of TNFR2 signaling in cancer cells and the tumor microenvironment and the potency of TNFR2 targeted therapy
H Takahashi, G Yoshimatsu, DL Faustman - Cells, 2022 - mdpi.com
The appreciation that cancer growth is promoted by a dynamic tumor microenvironment
(TME) has spawned novel approaches to cancer treatment. New therapies include agents …
(TME) has spawned novel approaches to cancer treatment. New therapies include agents …
Epithelial nuclear factor-κB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes
R Zaynagetdinov, GT Stathopoulos, TP Sherrill… - Oncogene, 2012 - nature.com
The mechanisms by which chronic inflammatory lung diseases, particularly chronic
obstructive pulmonary disease, confer enhanced risk for lung cancer are not well-defined …
obstructive pulmonary disease, confer enhanced risk for lung cancer are not well-defined …
相关搜索
- nf κb lung cancer
- nf κb cell dedifferentiation
- tnf axis cancer progression
- nf κb immunosuppressive microenvironment
- tumor microenvironment cancer cells
- immunosuppressive microenvironment lung cancer
- nf κb pdl1 transcription
- nf κb immune evasion
- nf κb tgf β
- pdl1 transcription lung cancer
- checkpoint inhibition lung cancer
- immune evasion lung cancer
- friend or foe lung cancer
- tgf β lung cancer